We are using the Illumina truseq DNA adapter prep kit. We are now doing whole genome and went to using the SYBR gold as illumina suggested. I had used SYBR safe and gotten low yield so they suggested SYBR gold as per protocol. We have done it twice and our ladders and/or samples are not running properly. Our 100bp ladder just looks like a big smear. These were about 2% agarose TAE gels. The ladder is from bioexpress. Is there something about SYBR gold that would be causing this? Is there some change we need to implement? Just to clarify, we add 15ul SYBR gold to about 120ml agarose pre gel-electrophoresis.
-
-
We never tried this--the instructions for SYBR-gold imply that it must be used only as a post-stain. I was surprised to see Illumina recommending that it be used during the run.
Also, I don't see how using SYBR-gold instead of SYBR-safe would increase your yield. I had only seen SYBR-gold suggested as a method to avoid the forked-adapter migration artifacts that one sometimes sees. But I would much prefer ETHANol's doing a few cycles of PCR prior to running the gel method to swapping out my running dye.
--
Phillip -
You may need to cut back on the amount of ladder that you are loading. I have seen that when using very sensitive dyes (GelStar, GelRed, most of the Sybr stains) you need to cut back on the amount of ladder that you use by 5-10x. If you use the same amount as you would for an EtBr gel, you end up with a big smear.
I agree with pmiguel, too, as I thought Sybr-Gold is supposed to be used for post staining only.Comment
-
I have used SYBR gold with great success, mixed into the gel as Illumina suggests. I used Benchtop ladder, which was also suggested in the manual, which does resolve quite clearly. It could be that the Bioexpress ladder is created in such a way that it does not resolve well with SYBR gold staining (maybe it has overhangs) - try looking up that information or maybe using less ladder as the others suggest.- GinaComment
-
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM -
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...
Comment